Also uncle Bill let the company fall to a 2,2 Cent cap raise, good for those that brought but Gourlay is not going to let that happen.
I believe he will do a deal with Fragile X before or very close after trials to minimise any dilution with a cap raise if indeed thats the way we go.
We are still way off current market value and I suspect the 3rd target may also be an MC growth announcement.
Just guessing, DYOR
Valuing An Early Stage Pharma, page-14
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
-0.001(3.70%) |
Mkt cap ! $70.50M | |||
| Open | High | Low | Value | Volume |
| 2.6¢ | 2.8¢ | 2.6¢ | $324.6K | 12.16M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 7020618 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 372676 | 2 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| ACW (ASX) Chart |